ABBOTT LABORATORIES (ABL.DE) Stock Fundamental Analysis
FRA:ABL - Deutsche Boerse Ag - US0028241000 - Common Stock - Currency: EUR
We assign a fundamental rating of 6 out of 10 to ABL. ABL was compared to 53 industry peers in the Health Care Equipment & Supplies industry. ABL has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ABL is not valued too expensively and it also shows a decent growth rate. These ratings would make ABL suitable for quality investing!
1. Profitability
1.1 Basic Checks
ABL had positive earnings in the past year.
In the past year ABL had a positive cash flow from operations.
Each year in the past 5 years ABL has been profitable.
ABL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
ABL has a Return On Assets of 16.46%. This is amongst the best in the industry. ABL outperforms 92.45% of its industry peers.
ABL has a Return On Equity of 28.12%. This is amongst the best in the industry. ABL outperforms 94.34% of its industry peers.
The Return On Invested Capital of ABL (8.98%) is better than 79.25% of its industry peers.
ABL had an Average Return On Invested Capital over the past 3 years of 10.45%. This is above the industry average of 8.33%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.46% | ||
| ROE | 28.12% | ||
| ROIC | 8.98% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
1.3 Margins
ABL's Profit Margin of 31.95% is amongst the best of the industry. ABL outperforms 98.11% of its industry peers.
ABL's Profit Margin has improved in the last couple of years.
ABL has a better Operating Margin (16.77%) than 83.02% of its industry peers.
ABL's Operating Margin has improved in the last couple of years.
ABL's Gross Margin of 55.66% is in line compared to the rest of the industry. ABL outperforms 50.94% of its industry peers.
ABL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.77% | ||
| PM (TTM) | 31.95% | ||
| GM | 55.66% |
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ABL is creating some value.
Compared to 1 year ago, ABL has about the same amount of shares outstanding.
The number of shares outstanding for ABL has been reduced compared to 5 years ago.
The debt/assets ratio for ABL has been reduced compared to a year ago.
2.2 Solvency
ABL has an Altman-Z score of 5.76. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
ABL has a Altman-Z score of 5.76. This is amongst the best in the industry. ABL outperforms 92.45% of its industry peers.
The Debt to FCF ratio of ABL is 2.22, which is a good value as it means it would take ABL, 2.22 years of fcf income to pay off all of its debts.
ABL has a Debt to FCF ratio of 2.22. This is amongst the best in the industry. ABL outperforms 83.02% of its industry peers.
ABL has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
ABL has a Debt to Equity ratio of 0.26. This is in the better half of the industry: ABL outperforms 62.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 2.22 | ||
| Altman-Z | 5.76 |
ROIC/WACC0.99
WACC9.08%
2.3 Liquidity
ABL has a Current Ratio of 1.67. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.67, ABL is in line with its industry, outperforming 50.94% of the companies in the same industry.
A Quick Ratio of 1.23 indicates that ABL should not have too much problems paying its short term obligations.
ABL has a Quick ratio of 1.23. This is in the better half of the industry: ABL outperforms 62.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.23 |
3. Growth
3.1 Past
ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.88%, which is quite good.
Measured over the past 5 years, ABL shows a small growth in Earnings Per Share. The EPS has been growing by 7.59% on average per year.
Looking at the last year, ABL shows a small growth in Revenue. The Revenue has grown by 5.00% in the last year.
Measured over the past years, ABL shows a small growth in Revenue. The Revenue has been growing by 5.63% on average per year.
EPS 1Y (TTM)8.88%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%11.22%
Revenue 1Y (TTM)5%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%3.95%
3.2 Future
ABL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.75% yearly.
Based on estimates for the next years, ABL will show a small growth in Revenue. The Revenue will grow by 6.77% on average per year.
EPS Next Y11.46%
EPS Next 2Y10.84%
EPS Next 3Y10.72%
EPS Next 5Y9.75%
Revenue Next Year5.65%
Revenue Next 2Y6.52%
Revenue Next 3Y6.8%
Revenue Next 5Y6.77%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 27.20 indicates a quite expensive valuation of ABL.
Based on the Price/Earnings ratio, ABL is valued a bit cheaper than the industry average as 75.47% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of ABL to the average of the S&P500 Index (28.92), we can say ABL is valued inline with the index average.
With a Price/Forward Earnings ratio of 22.68, ABL is valued on the expensive side.
ABL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ABL is cheaper than 67.92% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.65, ABL is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.2 | ||
| Fwd PE | 22.68 |
4.2 Price Multiples
ABL's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABL indicates a somewhat cheap valuation: ABL is cheaper than 67.92% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 35.53 | ||
| EV/EBITDA | 22.53 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABL does not grow enough to justify the current Price/Earnings ratio.
ABL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.37
PEG (5Y)3.59
EPS Next 2Y10.84%
EPS Next 3Y10.72%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.80%, ABL has a reasonable but not impressive dividend return.
ABL's Dividend Yield is a higher than the industry average which is at 2.45.
Compared to the average S&P500 Dividend Yield of 2.51, ABL is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.8% |
5.2 History
The dividend of ABL is nicely growing with an annual growth rate of 11.40%!
Dividend Growth(5Y)11.4%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
ABL pays out 28.62% of its income as dividend. This is a sustainable payout ratio.
ABL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.62%
EPS Next 2Y10.84%
EPS Next 3Y10.72%
FRA:ABL (4/24/2025, 7:00:00 PM)
113.98
+0.22 (+0.19%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners79.14%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap197.68B
Analysts80
Price Target129.47 (13.59%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.8% |
Yearly Dividend1.95
Dividend Growth(5Y)11.4%
DP28.62%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.75%
Min EPS beat(2)-1.16%
Max EPS beat(2)-0.34%
EPS beat(4)2
Avg EPS beat(4)0.58%
Min EPS beat(4)-1.16%
Max EPS beat(4)2.22%
EPS beat(8)5
Avg EPS beat(8)1.17%
EPS beat(12)9
Avg EPS beat(12)6.97%
EPS beat(16)13
Avg EPS beat(16)9.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.76%
Min Revenue beat(2)-1.33%
Max Revenue beat(2)-0.19%
Revenue beat(4)0
Avg Revenue beat(4)-0.65%
Min Revenue beat(4)-1.33%
Max Revenue beat(4)-0.15%
Revenue beat(8)3
Avg Revenue beat(8)0.18%
Revenue beat(12)7
Avg Revenue beat(12)2.21%
Revenue beat(16)10
Avg Revenue beat(16)2.94%
PT rev (1m)-0.5%
PT rev (3m)1.03%
EPS NQ rev (1m)0.09%
EPS NQ rev (3m)-3.37%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)-0.13%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)-2.52%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)-1.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.2 | ||
| Fwd PE | 22.68 | ||
| P/S | 5.38 | ||
| P/FCF | 35.53 | ||
| P/OCF | 26.37 | ||
| P/B | 4.73 | ||
| P/tB | 12.6 | ||
| EV/EBITDA | 22.53 |
EPS(TTM)4.19
EY3.68%
EPS(NY)5.03
Fwd EY4.41%
FCF(TTM)3.21
FCFY2.81%
OCF(TTM)4.32
OCFY3.79%
SpS21.19
BVpS24.08
TBVpS9.05
PEG (NY)2.37
PEG (5Y)3.59
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.46% | ||
| ROE | 28.12% | ||
| ROCE | 10.46% | ||
| ROIC | 8.98% | ||
| ROICexc | 10.19% | ||
| ROICexgc | 20.46% | ||
| OM | 16.77% | ||
| PM (TTM) | 31.95% | ||
| GM | 55.66% | ||
| FCFM | 15.14% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
ROICexc(3y)12.18%
ROICexc(5y)11.89%
ROICexgc(3y)32.65%
ROICexgc(5y)35.03%
ROCE(3y)12.16%
ROCE(5y)11.86%
ROICexcg growth 3Y-24.08%
ROICexcg growth 5Y-8.19%
ROICexc growth 3Y-10.71%
ROICexc growth 5Y6.04%
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 2.22 | ||
| Debt/EBITDA | 1.23 | ||
| Cap/Depr | 68.58% | ||
| Cap/Sales | 5.26% | ||
| Interest Coverage | 11.65 | ||
| Cash Conversion | 83.46% | ||
| Profit Quality | 47.39% | ||
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.23 | ||
| Altman-Z | 5.76 |
F-Score7
WACC9.08%
ROIC/WACC0.99
Cap/Depr(3y)63.63%
Cap/Depr(5y)61.92%
Cap/Sales(3y)4.94%
Cap/Sales(5y)5.1%
Profit Quality(3y)82.78%
Profit Quality(5y)99.6%
High Growth Momentum
Growth
EPS 1Y (TTM)8.88%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%11.22%
EPS Next Y11.46%
EPS Next 2Y10.84%
EPS Next 3Y10.72%
EPS Next 5Y9.75%
Revenue 1Y (TTM)5%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%3.95%
Revenue Next Year5.65%
Revenue Next 2Y6.52%
Revenue Next 3Y6.8%
Revenue Next 5Y6.77%
EBIT growth 1Y4.67%
EBIT growth 3Y-6.62%
EBIT growth 5Y8.41%
EBIT Next Year27.12%
EBIT Next 3Y15.31%
EBIT Next 5Y10.73%
FCF growth 1Y25.54%
FCF growth 3Y-9.78%
FCF growth 5Y7.14%
OCF growth 1Y17.86%
OCF growth 3Y-6.69%
OCF growth 5Y6.88%